
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs
Zuzana Tatárová, Dylan C. Blumberg, James E. Korkola, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 12, pp. 1823-1833
Open Access | Times Cited: 37
Zuzana Tatárová, Dylan C. Blumberg, James E. Korkola, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 12, pp. 1823-1833
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Rational combinations of targeted cancer therapies: background, advances and challenges
Haojie Jin, Liqin Wang, René Bernards
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 213-234
Closed Access | Times Cited: 246
Haojie Jin, Liqin Wang, René Bernards
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 213-234
Closed Access | Times Cited: 246
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Exosome camouflaged coordination-assembled Iridium(III) photosensitizers for apoptosis-autophagy-ferroptosis induced combination therapy against melanoma
Tao Feng, Zixin Tang, Johannes Karges, et al.
Biomaterials (2023) Vol. 301, pp. 122212-122212
Closed Access | Times Cited: 45
Tao Feng, Zixin Tang, Johannes Karges, et al.
Biomaterials (2023) Vol. 301, pp. 122212-122212
Closed Access | Times Cited: 45
Optimizing kinase and PARP inhibitor combinations through machine learning and in silico approaches for targeted brain cancer therapy
Alireza Poustforoosh
Molecular Diversity (2025)
Closed Access | Times Cited: 2
Alireza Poustforoosh
Molecular Diversity (2025)
Closed Access | Times Cited: 2
Feasibility of MRI ‐Guided Transperineal Implantation of Microdevices for Drug Delivery and Response Assessment in Prostate Cancer
Quinn Rainer, Kemal Tuncali, W. S. Ahn, et al.
Journal of Magnetic Resonance Imaging (2025)
Closed Access | Times Cited: 1
Quinn Rainer, Kemal Tuncali, W. S. Ahn, et al.
Journal of Magnetic Resonance Imaging (2025)
Closed Access | Times Cited: 1
Emerging frontiers in drug delivery with special focus on novel techniques for targeted therapies
Ling Yu, Shengmao Liu, Shengnan Jia, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115049-115049
Open Access | Times Cited: 22
Ling Yu, Shengmao Liu, Shengnan Jia, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115049-115049
Open Access | Times Cited: 22
Implantable Microneedle‐Mediated Eradication of Postoperative Tumor Foci Mitigates Glioblastoma Relapse
Yulin Zhang, Z Fang, Zejuan Liu, et al.
Advanced Materials (2024)
Open Access | Times Cited: 8
Yulin Zhang, Z Fang, Zejuan Liu, et al.
Advanced Materials (2024)
Open Access | Times Cited: 8
Targeting Tumor Microenvironment by Metal Peroxide Nanoparticles in Cancer Therapy
Simon N. Mbugua
Bioinorganic Chemistry and Applications (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 26
Simon N. Mbugua
Bioinorganic Chemistry and Applications (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 26
The past, present, and future of chemotherapy with a focus on individualization of drug dosing
Louis DeRidder, Douglas A. Rubinson, Róbert Langer, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 840-860
Closed Access | Times Cited: 22
Louis DeRidder, Douglas A. Rubinson, Róbert Langer, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 840-860
Closed Access | Times Cited: 22
Checkpoint inhibitors and anti-angiogenic agents: a winning combination
Patrick Brest, Baharia Mograbi, Gilles Pagès, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 9, pp. 1367-1372
Open Access | Times Cited: 10
Patrick Brest, Baharia Mograbi, Gilles Pagès, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 9, pp. 1367-1372
Open Access | Times Cited: 10
Using the tumour microenvironment to improve therapy efficacy
Zuzana Tatárová
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 444-444
Closed Access | Times Cited: 3
Zuzana Tatárová
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 444-444
Closed Access | Times Cited: 3
Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds
Elahe Minaei, Marie Ranson, Morteza Aghmesheh, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 145-160
Open Access | Times Cited: 3
Elahe Minaei, Marie Ranson, Morteza Aghmesheh, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 145-160
Open Access | Times Cited: 3
Digitize your Biology! Modeling multicellular systems through interpretable cell behavior
Jeanette Johnson, Genevieve Stein-O’Brien, M. Booth, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Jeanette Johnson, Genevieve Stein-O’Brien, M. Booth, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Fine-tuning the sequential drug release of nano-formulated mutual prodrugs dictates the combination effects
Haiping Zhong, Xingwei Li, Na Yu, et al.
Chemical Science (2023) Vol. 14, Iss. 14, pp. 3789-3799
Open Access | Times Cited: 8
Haiping Zhong, Xingwei Li, Na Yu, et al.
Chemical Science (2023) Vol. 14, Iss. 14, pp. 3789-3799
Open Access | Times Cited: 8
Human serum albumin and sialic acid co-modified liposome nanoreactors with tumor-specific activable cascade reactions for cooperative cancer therapy
Jinling Ge, Ke Zhou, Yuanyuan Li, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105343-105343
Closed Access | Times Cited: 2
Jinling Ge, Ke Zhou, Yuanyuan Li, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105343-105343
Closed Access | Times Cited: 2
Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions
Koustav Pal, Rahul A. Sheth
Cancers (2022) Vol. 15, Iss. 1, pp. 196-196
Open Access | Times Cited: 9
Koustav Pal, Rahul A. Sheth
Cancers (2022) Vol. 15, Iss. 1, pp. 196-196
Open Access | Times Cited: 9
Ex Vivo Evaluation of Combination Immunotherapy Using Tumor‐Microenvironment‐on‐Chip
Hsuan‐Yu Mu, Chiao‐Min Lin, Li‐An Chu, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 5
Hsuan‐Yu Mu, Chiao‐Min Lin, Li‐An Chu, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 5
Single-cell morphodynamical trajectories enable prediction of gene expression accompanying cell state change
Jeremy Copperman, Ian C. McLean, Sean M. Gross, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Jeremy Copperman, Ian C. McLean, Sean M. Gross, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Two-site microendoscopic imaging probe for simultaneous three-dimensional imaging at two anatomic locations in tissues
Guigen Liu, Sebastian W. Ahn, Jeon Woong Kang, et al.
Optics Letters (2024) Vol. 49, Iss. 12, pp. 3312-3312
Open Access | Times Cited: 1
Guigen Liu, Sebastian W. Ahn, Jeon Woong Kang, et al.
Optics Letters (2024) Vol. 49, Iss. 12, pp. 3312-3312
Open Access | Times Cited: 1
Mismatch repair-proficient tumor footprints in the sands of immune desert: mechanistic constraints and precision platforms
Biswanath Majumder, Nishanth Belugali Nataraj, Leela Maitreyi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Biswanath Majumder, Nishanth Belugali Nataraj, Leela Maitreyi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Analysis of efficacy and safety for the combination of tislelizumab and regorafenib in advanced hepatocellular carcinoma: A prospective clinical study
Pengfei Sun, Ying Zhang, Shilin Tian, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 4, pp. 1344-1349
Open Access | Times Cited: 1
Pengfei Sun, Ying Zhang, Shilin Tian, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 4, pp. 1344-1349
Open Access | Times Cited: 1
Implantable Biomaterials for Cancer Immunotherapies
Н. А. Печникова, Amalia Aggeli, Anastasiia A. Latypova, et al.
Advanced Functional Materials (2024)
Open Access | Times Cited: 1
Н. А. Печникова, Amalia Aggeli, Anastasiia A. Latypova, et al.
Advanced Functional Materials (2024)
Open Access | Times Cited: 1
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell death
Karla Alvarez-Valadez, Allan Sauvat, Julien Diharce, et al.
Autophagy (2024), pp. 1-23
Closed Access | Times Cited: 1
Karla Alvarez-Valadez, Allan Sauvat, Julien Diharce, et al.
Autophagy (2024), pp. 1-23
Closed Access | Times Cited: 1
Microdissected tumor cuboids: a microscale cancer model that retains a complex tumor microenvironment
Lisa F. Horowitz, Ricard A. Rodríguez‐Mias, Marina Chan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Lisa F. Horowitz, Ricard A. Rodríguez‐Mias, Marina Chan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response
Justine De Azevedo, Jana Mourtada, Cyril Bour, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2866-2866
Open Access | Times Cited: 6
Justine De Azevedo, Jana Mourtada, Cyril Bour, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2866-2866
Open Access | Times Cited: 6